A neurological disease paradigm shift
Researchers propose a new model for classifying Parkinson’s
One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson’s is also currently made very late, after the disease may have been in the brain for a decade or more.
Sleep disorder linked to neurodegeneration is focus of $35 million USD grant
International team seeks hidden signs of brain damage in REM behavior disorderPeople with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their arms to catch an imaginary ball, or try to run from an illusory assailant. Such actions are more than just a nuisance.
Using sleep disorder to predict Parkinson’s disease
Large international study will help select and categorize patients for better clinical trials
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.
The Neuro marks Parkinson’s Awareness Month
April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.
April is Parkinson’s Awareness Month
Multidisciplinary care and cutting-edge research share space at The NeuroThe Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties.
The Neuro – A Major Force in Parkinson’s Disease Research and Treatment
The Neuro – A Major Force in Parkinson’s Disease Research and TreatmentFor many years, the Montreal Neurological Institute and Hospital (The Neuro) and the Research Institute of the McGill University Health Centre have conducted studies that have led to a greater understanding of the nature of Parkinson’s disease (PD). About 100,000 Canadians have PD, a motor neuron disease generally associated with old age, but which can also appear in a person’s thirties or forties.
Parkinson's disease: a new tool for health care professionals aims to improve diagnosis and advance treatment
The results of their study, published in the journal Movement Disorders.
April - Parkinson’s Disease Awareness Month
The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.
The Neuro to introduce experimental drug treatment